Get the Stockscreener App
3.23
0.31%
0.010
After Hours:
3.25
0.02
+0.62%
Climb Bio Inc stock is traded at $3.23, with a volume of 58,921.
It is up +0.31% in the last 24 hours and down -20.05% over the past month.
Climb Bio Inc is a clinical-stage biotechnology company developing therapeutics for patients with immune-mediated diseases. its lead product candidate, budoprutug, is an anti-CD19 monoclonal antibody that has demonstrated B-cell depletion and has the potential to treat a broad range of B-cell-mediated diseases.
See More
Previous Close:
$3.22
Open:
$3.24
24h Volume:
58,921
Relative Volume:
0.32
Market Cap:
$217.13M
Revenue:
-
Net Income/Loss:
$-64.20M
P/E Ratio:
-
EPS:
-
Net Cash Flow:
$57,000
1W Performance:
+5.90%
1M Performance:
-20.05%
6M Performance:
+0.00%
1Y Performance:
+0.00%
1-Day Range:
$3.19
$3.29
1-Week Range:
$2.98
$3.29
52-Week Range:
$2.90
$5.47
Climb Bio Inc Stock (CLYM) Company Profile
Name
Climb Bio Inc
Sector
Industry
Phone
1-866-857-2596
Address
20 WILLIAM STREET, WELLESLEY HILLS
Compare CLYM with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CLYM
Climb Bio Inc
|
3.23 | 217.13M | 0 | -64.20M | 57,000 | -2.15 |
|
VRTX
Vertex Pharmaceuticals Inc
|
468.13 | 120.56B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
750.22 | 82.44B | 13.85B | 4.65B | 3.32B | 40.41 |
|
ARGX
Argen X Se Adr
|
616.55 | 36.87B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
253.07 | 32.64B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
118.39 | 28.38B | 3.30B | -501.07M | 1.03B | -2.1146 |
Climb Bio Inc Stock (CLYM) Latest News
A Look At The Behavior Of Kronos Bio Inc (KRON) Stock - Stocks Register
S&P 500, Nasdaq climb; markets analyze Trump's tariff threats, Fed minutes - Yahoo Finance
Helio Genomics Presented CLiMB Trial Data Evaluating HelioLiver for Detecting Early-Stage HCC and Methylation Model Score for Assessing Prognosis at AASLD and Virtual KOL Event, Featuring Chief Medical Advisor Dr. Richard Van Etten, MD, PhD - Yahoo Finance
Base Metals Climb as Dollar Drops After Trump’s Treasury Choice - Yahoo Finance
Bets on ‘Trump Put’ Send Stocks, Bitcoin Higher: Markets Wrap - Yahoo Finance
Oil prices climb 1% to two-week high as Ukraine war intensifies - Yahoo Finance
Zacks.com featured highlights Sezzle, Kingstone, Graham, Interface and Climb Global - Yahoo Finance
Are Wall Street Analysts Predicting Bio-Techne Stock Will Climb Or Sink? - Barchart
Dow Jones, Small Caps Climb More Than 1%, But Google Stock Weighs On Techs (Live Coverage) - Yahoo! Voices
Are Wall Street Analysts Predicting Bio-Techne Stock Will Climb or Sink? - Nasdaq
Mortgage rates resume climb toward 7% - Yahoo Finance
As National Sales of E-Cigarettes Climb, Report Shows that State Restrictions on Flavored Products Are Critical to Protect Young People - Yahoo Finance
Some Confidence Is Lacking In ABL Bio Inc. (KOSDAQ:298380) As Shares Slide 30% - Simply Wall St
Nvidia Shares To Climb Over $140+ Levels, Says Technical Analyst Ahead Of Q3 Results: '...Will Have To Beat Street Expectations For The Trend To Continue' - Yahoo Finance
Are Wall Street Analysts Predicting KKR Stock Will Climb or Sink? - MSN
Domino's, Pool Corp. Climb After Buffett's Berkshire Buys Stake - RTTNews
Can Cannae (CNNE) Climb 35.44% to Reach the Level Wall Street Analysts Expect? - Yahoo Finance
Deep Track Capital, LP Reduces Stake in Climb Bio Inc - GuruFocus.com
Are Business Services Stocks Lagging Climb Global Solutions, Inc. (CLMB) This Year? - Yahoo Finance
Sri Lankan Stocks Climb, Information Technology Leads The Way - Finimize
Mortgage rates fall slightly, ending 6-week climb - Yahoo Finance
Climb Bio Inc. Shifts Focus to Immune-Mediated Diseases - TipRanks
iBio Reports Fiscal First Quarter 2025 Financial Results - The Manila Times
Climb Bio Reports Third Quarter 2024 Financial Results and Business Highlights - GlobeNewswire
Climb Bio Secures FDA Clearance for SLE Drug Trial, Reports $217.9M Cash Position | CLYM Stock News - StockTitan
Climb Bio Appoints Douglas E. Williams, Ph.D., as Chair of the Board - GlobeNewswire
Climb Bio Appoints Biotech Veteran Douglas Williams as Board Chair, Strengthens Leadership | CLYM Stock News - StockTitan
S&P 500 Surpasses 6K for First Time After Climbing 1K Points in Record Time - Yahoo Finance
Sales climb for EcoSynthetix Inc. in Q3 - Pulp & Paper Canada
Palantir Raises 2024 Forecast Amid Booming Demand for AI Solutions, Shares Climb 14% - Yahoo Finance
Sherwin-Williams Shares Climb as It Prepares to Join Dow, Replacing Dow Inc. - Yahoo Finance
Climb Global Solutions Inc (CLMB) Q3 2024 Earnings Call Highlights: Record Growth and Strategic ... - Yahoo Finance
Climb Bio to Present at Upcoming Investor Conferences - GlobeNewswire
Nasdaq Futures Climb on Upbeat Alphabet Results, U.S. GDP Data and More Big Tech Earnings on Tap - MSN
Humic Acid Market Set to Climb to USD 1.63 Billion by 2030 - openPR
ABVC BioPharma receives $50,000 in incremental licensing fees, shares climb - MSN
Why Tesla Stock Was Climbing This Week - Yahoo Finance
Tevogen Bio (TVGN) Sees Major Stock Surge After Key AI Move - Stocks Telegraph
Interpublic Group Of Cos., Inc. (IPG): Worth A Small Bite At $32.03 - Stocks Register
Why Lamb Weston Stock Was Climbing Today - Yahoo Finance
Big Bank Stocks Climb. 3 Stocks to Consider Adding to Your Portfolio. - Yahoo Finance
Merck & Co’s Clesrovimab Has Beyfortus Hill To Climb In RSV - Citeline News & Insights
Treasury Yields Climb as Strong Data Sow Doubt on Fed Rate Cuts - Yahoo Finance
Mortgage Demand Sees Sharpest Weekly Drop Since April 2020 As Rates Climb Above 6.5% - Yahoo Finance
Korean growth stocks climb after rate cut - 코리아타임스
Vale Achieves Six-Year High in Iron Ore Output, Copper and Nickel Production Also Climb - Yahoo Finance
European Wax Center Continues to Climb in Franchise Times' Top 400 Ranking - Yahoo Finance
US Mortgage Rates Climb to 6.52%, Highest Since Early August - Yahoo Finance
What You Need to Know Ahead of Bio-Techne's Earnings Release - TradingView
Stocks of B. Riley Financial Inc (RILY) are poised to climb above their peers - SETE News
Climb Bio to Provide Budoprutug Development Strategy and Corporate Update at Virtual Investor Event - The Manila Times
Climb Bio Inc Stock (CLYM) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.61%
1.14%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):